LXRX - Lexicon Pharmaceuticals Inc
IEX Last Trade
1.73
-0.070 -4.046%
Share volume: 3,307,233
Last Updated: Fri 30 Aug 2024 09:59:51 PM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$1.80
-0.07
-3.89%
Summary score
13%
Profitability
0%
Dept financing
11%
Liquidity
75%
Performance
10%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2020 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-16.69%
Return on assets
-15.36%
Return on sales
-53591.91%
Return on invested capital
-106.29%
Total debt ratio
34.32%
Debt ratio change over timeo
-1.23%
Current Ratio
6.08%
Quick Ratio
6.08%
Cash Position Ratio
5.9%
Short-term ratios 30-Jun-2023 - 30-Jun-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
-32.17%
Return on assets
-16%
Return on sales
-11169.07%
Return on invested capital
-214.59%
Total debt ratio
43.86%
Debt ratio change over timeo
-1.21%
Current Ratio
9.9%
Quick Ratio
9.89%
Cash Position Ratio
9.62%
Last quarter ratios 30-Jun-2024
The data are presented for the financials results of the last quarter.
Return on equity
-22.26%
Return on assets
-14.83%
Return on sales
-3360.9%
Return on invested capital
-216.87%
Total debt ratio
35.72%
Debt ratio change over time
-1.16%
Current Ratio
11.51%
Quick Ratio
11.49%
Cash Position Ratio
11.12%
Performance ratios (change over 4 years) 30-Jun-2020 - 30-Jun-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-81.06%
Return on assets
-88.92%
Return on sales
49541.66%
Return on invested capital
-36.17%
Total debt ratio
-123.46%
Debt ratio change over time
-1.23%
Current Ratio
-5.33%
Quick Ratio
-5.33%
Cash Position Ratio
-5.21%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | LXRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -16.69% | 15.05% | 35.64% | 7.13% |
| Return on assets | -15.36% | 2.88% | 3.13% | 5.53% |
| Return on sales | -53591.91% | 29.62% | 32.25% | 40.49% |
| Return on invested capital | -106.29% | 2.57% | 5.37% | 18.48% |
| Profitability | 0% | 45% | 66% | 80% |
| Total debt ratio | 34.32% | 90.48% | 91% | 25.78% |
| Debt ratio change over time | -1.23% | 326.95% | -8.44% | 1.18% |
| Dept financing | 9% | 50% | 25% | 7% |
| Current Ratio | 9.9% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 9.89% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 9.62% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 8% | 18% | 44% |
| Short-term ratios | LXRX | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -32.17% | 13.14% | 10.88% | 4.07% |
| Return on assets | -16% | 2.1% | 1.54% | 3.03% |
| Return on sales | -11169.07% | 21.74% | 18.43% | 30.26% |
| Return on invested capital | -214.59% | 1.95% | 2.74% | 9.55% |
| Profitability | 0% | 65% | 56% | 83% |
| Total debt ratio | 43.86% | 92.68% | 93.24% | 21.84% |
| Debt ratio change over time | -1.21% | 51.04% | -101.54% | 1.43% |
| Dept financing | 12% | 50% | 25% | 7% |
| Current Ratio | 9.9% | 0.92% | 1.98% | 5.39% |
| Quick Ratio | 9.89% | 0.81% | 1.56% | 4.63% |
| Cash Position Ratio | 9.62% | 0.39% | 1.05% | 2.91% |
| Liquididy | 75% | 5% | 12% | 33% |